TNF-α plays a role in hepatocyte apoptosis in Niemann-Pick type C liver disease
Victoria M. Rimkunas, Mark J. Graham, Rosanne M. Crooke and 1 more
Journal of Lipid Research · 2009
doi:10.1194/jlr.m800415-jlr200 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Niemann-Pick type C (NPC) is a fatal autosomal recessive lysosomal storage disease clinically characterized by neurodegeneration and liver disease. Heterogeneous mutations in the NPC1 and NPC2 genes cause impaired egress of free cholesterol from lysosomes, leading to accumulation of cholesterol and glycosphingolipids. Key features of NPC liver disease include hepatic apoptosis, inflammation, and fibrosis. It is unclear what signaling events regulate these disease processes in NPC. We hypothesize that tumor necrosis factor α (TNF-α), which is involved in both proinflammatory and apoptotic signaling cascades, is a key mediator of inflammation, apoptosis, and fibrosis in NPC liver disease. In this study, we evaluated the role of TNF-α signaling in NPC liver disease by utilizing NPC1-specific antisense oligonucleotides to knock down NPC1 expression in control and TNF-α knockout mice. In the absence of TNF-α, NPC1 knockdown produced liver disease with significantly less inflammation, apoptosis, and fibrosis.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.